Author

Xin‐zhuan Su

National Institutes of HealthORCID 0000-0003-3246-3248Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2

Frequent Co-Authors

Awet Alem TeklemichaeliD· 2 shared Brian J. CurtisiD· 2 shared Christina M. McBrideiD· 2 shared David H. ShermaniD· 2 shared Erin N. OliphantiD· 2 shared Filipa M. PereiraiD· 2 shared James IngleseiD· 2 shared Linnea Verhey-Henke· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Awet Alem TeklemichaelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryOrganic & Biomolecular ChemistryPeer-reviewedJan 1, 2026

Chemoselective Halogenation of Premarineosin A for Next-Generation Antimalarial Development

Natalia R. Harris, Sahar Amin, Brian J. Curtis…·Filipa M. Pereira

The paper reports chemoselective halogenation of Premarineosin A, yielding analogs with retained antiplasmodial activity against both sensitive and resistant Plasmodium falciparum strains.

DOI 10.1039/d6ob01037g

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologyCommunications ChemistryPeer-reviewedDec 5, 2025

Metabolic engineering and late-stage functionalization expand the chemical space of the antimalarial premarineosin A

Christina M. McBride, Morgan McCauley, Natalia R. Harris…·David H. Sherman

This study uses metabolic engineering and late-stage functionalization to expand the chemical diversity of the antimalarial compound premarineosin A, identifying potent analogs.

2 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky